Brain Protection Treatment for Recent Stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a neuroprotective treatment (a medication designed to protect brain cells) in patients with acute ischemic stroke—a stroke caused by a blood clot. The goal is to see if the treatment can reduce brain damage and improve recovery when given within 48 hours of stroke symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have had an ischemic stroke (caused by a blood clot) in the middle cerebral artery territory, confirmed by a neurologist and imaging scans
- Your stroke symptoms started within 48 hours before evaluation (or within 48 hours of when you were last seen well, if the exact time is unknown)
- Your stroke severity score (NIHSS) is at least 6 at the time of enrollment
- You have not had a previous stroke with lasting disability, or if you have, your disability is minimal (mRS score of 1 or less)
- You are not currently taking certain brain-protective medications like memantine, ketamine, or lamitrigine, and you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a simple remote “arm conditioning” treatment started soon after an acute ischemic stroke can improve outcomes and safety. It may help some patients recover better by supporting the body’s protective response to stroke.
This trial tests a safe, non-invasive brain stimulation technique called tDCS to help people recover from a recent stroke. It's for people who cannot have the standard clot-removal procedure and who can start treatment within 24 hours of their stroke.
This trial tests if a procedure to remove blood clots from brain arteries can help people who had a stroke more than 24 hours ago (up to 30 days). It aims to see if this treatment improves recovery for those with moderate to severe stroke symptoms.
This study tests a structured, fast way of treating people who have a new ischemic stroke (a stroke caused by a blocked blood vessel). It may help because it focuses on getting the right stroke treatments quickly and consistently.
This study tests an experimental drug called BB-031 to see if it can safely help people who have had a recent ischemic stroke (a clot that blocks blood flow to the brain). The trial is for people who can get to the hospital within 24 hours of their first symptoms and have a moderate to severe stroke.
This trial studies a protective “conditioning” treatment given during air ambulance transport for people with a suspected large-vessel ischemic stroke. The goal is to reduce further brain injury and preserve more brain tissue while you’re being transported for stroke care.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.